Genprex, Inc.
SEC CIK 1595248 · GNPX · last insider filing 2026-04-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Longnecker Brent M | Director | filed 2020 - 2026 |
| Confer Ryan M. | Director · President, CEO and CFO | filed 2018 - 2026 |
| Moreno Toscano Jose Antonio | Director | filed 2020 - 2025 |
| Wilson William R Jr. | Director | filed 2020 - 2025 |
| Varner John Rodney | Director · President & CEO | filed 2018 - 2024 |
| Pearson Robert W. | Director | filed 2018 - 2020 |
| Friedman David E. | Director | filed 2018 - 2020 |
| Bonfiglio John N | Director | filed 2019 - 2019 |
| Genprex, Inc. | Director · Chief Executive Officer | filed 2018 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Berger Mark Stanley | Chief Medical Officer | filed 2021 - 2026 |
| Vaczy Catherine M | EVP GC Chief Strategy Officer | filed 2020 - 2023 |
| Kumar Hermant | Chief Mfgr & Tech Officer | filed 2021 - 2023 |
| Redman Michael Thomas | EVP & Chief Operating Officer | filed 2020 - 2021 |
| Pham Julien L | President & COO | filed 2018 - 2019 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.